Latest news
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call - StockStoryStockStory · Fri, 07 Aug 2026 08:56:38 GMTWill Kymera (KYMR) New CMO Hire Quietly Reframe Its Immunology Execution Story? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 23:32:33 GMTABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset - StockStoryStockStory · Fri, 31 Jul 2026 07:00:00 GMT